Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 519 | 523 | 502 | 509 | 464 |
| Income taxes - deferred | 1,251 | 16 | 811 | -753 | 572 |
| Accounts receivable | 305 | -192 | 20,377 | -25,654 | 1,011 |
| Accounts payable and accrued liabilities | -842 | 2,223 | 699 | 1,300 | -492 |
| Other Working Capital | -600 | -15,746 | -2,676 | -23,222 | 1,091 |
| Other Operating Activity | 1,819 | 3,788 | -16,460 | 27,904 | 1,413 |
| Operating Cash Flow | $2,452 | $-9,388 | $3,253 | $-19,916 | $4,059 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | 0 | -107 | -9 | -44 |
| Purchase Of Investment | -89,721 | -106,000 | -140,374 | -147,686 | -242,997 |
| Sale Of Investment | 150,585 | 121,640 | 78,835 | 50,952 | 70,862 |
| Purchase Sale Intangibles | 0 | -1,989 | -670 | 0 | 0 |
| Other Investing Activity | 1,843 | -17,193 | -1,789 | 3,323 | 763 |
| Investing Cash Flow | $62,703 | $-3,542 | $-64,105 | $-93,420 | $-171,416 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -70 | -67 | N/A | N/A | N/A |
| Other Financing Activity | 56 | 60 | 51 | 148 | 42 |
| Financing Cash Flow | $-14 | $-7 | $51 | $148 | $42 |
| Exchange Rate Effect | -1,340 | -738 | 2,364 | -1,948 | 2,265 |
| Beginning Cash Position | 231,110 | 244,785 | 303,222 | 418,358 | 583,408 |
| End Cash Position | 294,911 | 231,110 | 244,785 | 303,222 | 418,358 |
| Net Cash Flow | $65,141 | $-12,937 | $-60,801 | $-113,188 | $-167,315 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,452 | -9,388 | 3,253 | -19,916 | 4,059 |
| Capital Expenditure | -4 | -1,989 | -777 | -9 | -44 |
| Free Cash Flow | 2,448 | -11,377 | 2,476 | -19,925 | 4,015 |